A new path for compliance-driven development: The impact of State Council Order No. 818 on biomedical innovation in China
-
-
REFERENCES
[1] Lu Z., Chen Y., Liu D., et al. (2023). The landscape of cancer research and cancer care in China. Nat. Med. 29:3022−3032. DOI:10.1038/s41591-023-02655-3 [2] The Central People's Government of the People's Republic of China. (2025). Regulations on Administration of Clinical Research and Clinical Translational Application of New Biomedical Technologies. Available online: https://www.gov.cn/gongbao/2025/issue_12346/202510/content_7044733.html (Accessed on May 31, 2026 [3] The Central People's Government of the People's Republic of China. Officials of the Ministry of Justice and the National Health Commission answer questions from the press on the regulations on administration of clinical research and clinical translational application of new biomedical technologies. Available online: https://www.gov.cn/zhengce/202510/content_7043887.htm (Accessed on May 31, 2026 [4] National Health Commission of the People's Republic of China and National Disease Control and Prevention Administration. Announcement on matters related to the implementation of the regulations on administration of clinical research and clinical translational application of new biomedical technologies. Available online: https://www.nhc.gov.cn/qjjys/c100016/202604/4238842553fd41a9a80c289c5132fc78.shtml (Accessed on May 31, 2026 [5] National Health Commission of the People's Republic of China. Notice of the National Health Commission on issuing the working specifications for the approval of clinical translational application of new biomedical technologies (for trial implementation). Available online: https://www.nhc.gov.cn/qjjys/c100016/202604/6d64fdc552ee49f4abba44831d189201.shtml (Accessed on June 24, 2026 -
ABOUT THIS ARTICLE
Cite this article:
Bian L., Guo J., Gao J., et al. (2026). A new path for compliance-driven development: The impact of State Council Order No. 818 on biomedical innovation in China. The Innovation Oncology 1:100016. https://doi.org/10.59717/j.xinn-oncol.2026.100016
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Bian L., Guo J., Gao J., et al. (2026). A new path for compliance-driven development: The impact of State Council Order No. 818 on biomedical innovation in China. The Innovation Oncology 1:100016. https://doi.org/10.59717/j.xinn-oncol.2026.100016
Format
Content
DownLoad:
-
Figure 1.
Management pathway for clinical research and clinical translational application of new biomedical technologies under the Regulations
